evaluate the pharmaceuticals company saxenda on amgen and glp-1 medications are marketed to help you lose weight, but one may be better at it than rest, according to a new meta-analysis from the UGA College of Pharmacy. Tirzepatide, better GLP-1 Market Trends and Global

Yaghubi E, Daneshpazhooh M, Mohammadi MDJ, Sepandar H, Fakhri F, Ghaedi Z, Keshavarz E, Balighi SA, Mahmoudi K

higher for those who stayed on treatment HbA1c fell by 1.91 percentage points from a mean baseline of 8.2% 73.5% of participants reached HbA1c 6.5%, a normal blood sugar threshold Compared to 15.9% with placebo Diabetes patients typically lose less weight on GLP-1 drugs than non-diabetic patients this pattern holds with CagriSema

Retatrutide: A triple-agonist (GLP-1/GIP/glucagon) that targets multiple metabolic pathways and has shown impressive weight loss results in studies

Register (free) for Daily Research News REGISTER FOR NEWS EMAILS To receive (free) news headlines by email, please register online